Insmed Incorporated
INSM
$116.00
$12.1111.66%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -163.56M | -328.49M | -370.02M | -321.69M | -256.58M |
| Total Depreciation and Amortization | 4.48M | 5.03M | 3.46M | 3.21M | 2.61M |
| Total Amortization of Deferred Charges | 2.59M | 2.59M | 2.56M | 2.89M | 3.03M |
| Total Other Non-Cash Items | -2.04M | 110.92M | 130.35M | 100.48M | 54.94M |
| Change in Net Operating Assets | -64.21M | -37.64M | 13.90M | 9.54M | -66.09M |
| Cash from Operations | -222.74M | -247.60M | -219.76M | -205.57M | -262.09M |
| Capital Expenditure | -3.48M | -16.59M | -2.42M | -3.48M | -10.07M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 269.00M | 406.00M | -759.82M | 231.32M | 90.48M |
| Cash from Investing | 265.52M | 389.41M | -762.23M | 227.84M | 80.41M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -799.00K | -776.00K | -747.00K | -2.70M | -706.00K |
| Issuance of Common Stock | 30.31M | 34.64M | 34.16M | 860.50M | 29.70M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 29.51M | 33.86M | 33.41M | 857.81M | 29.00M |
| Foreign Exchange rate Adjustments | -553.00K | 7.00K | -976.00K | 1.01M | 895.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 71.74M | 175.68M | -949.56M | 881.08M | -151.78M |